ABBVIE

ABBV

189.700
USD
4.38
(2.36%)
Market Closed
Volume
104,520
EPS
0
Div Yield
0
P/E
62
Market Cap
329,652,733,129

Signals

sara abdelazim
1 year ago
sell
ABBV@147.12
2023-08-23 15:21
Profit
7.5

Related Instruments

AZN
2.040
(2.58%)
81.200 USD
BMY
0.620
(1.30%)
48.180 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
NVS
0.650
(0.58%)
112.100 USD
PFE
0.115
(0.38%)
30.650 USD
SNY
-0.090
(-0.17%)
51.700 USD

News

Title: ABBVIE

Sector: Healthcare
Industry: Drug Manufacturers - General
AbbVie Inc. is an American biopharmaceutical firm that engages in research-based development, marketing and sales of pharmaceutical products. It was founded in 2011 as a spin-off of Abbott Laboratories, which planned to separate into two publicly traded companies. The new Abbott Laboratories would specialize in diversified products, including medical devices, diagnostic equipment and nutrition products, while AbbVie was slated to operate as a research-based pharmaceutical manufacturer. The separation came into effect on January 1, 2013. AbbVie was listed on the New York Stock Exchange on January 2, 2013. According to company statistics from December 2015, AbbVie Inc. employed more than 28,000 people globally and provided products to individuals in more than 170 countries. According to updated statistics from October 2022, the company now employs over 50,000 globally, reflecting impressive growth in key markets.